HTAi Rome 2017

Exhibitors

	The international Network of Agencies for Health Technology Assessment (INAHTA) is a network of 51 publicly-funded HTA agencies that support health system decision making that affects over 1 billion people in 31 countries around the globe. INAHTA brings HTA agencies together to share knowledge and tools to strengthen their role as essential contributors to health outcomes and health system sustainability.
	Cochrane is a global independent network of researchers, professionals, patients, carers and people interested in health. Cochrane produces reviews which study all of the best available evidence generated through research and make it easier to inform decisions about health. We offer a range of systematic review services tailored to the needs of commissioners.
	Decision Resources Group (DRG) is a global provider of healthcare analytics, data and insight products, and consulting services to the world’s leading pharmaceutical, biotech and medical technology companies. The DRG Abacus team provides integrated health economics and outcomes research, and market access solutions throughout the product life-cycle. We have an extensive experience in developing successful and supported evidence dossiers for submission to HTA bodies across the globe.
	The global strategic market access consultancy with 20 years thought leadership partnering with Pharma and Biotech clients. Experts in value strategy based on in-depth customer insights, creating value through clinical and HEOR evidence, achieving successful pricing, reimbursement and funding approval, brand launch and commercialisation. Unparalleled expertise in building market access and commercial capabilities for global, regional and country teams.
	INTEXO is an Italian leading company for Patient Access and Regulatory affairs solutions. Our expertise is to help Healthcare Companies accessing the Italian market carrying out integrated Patient Access projects, by combining regulatory procedures, scientific and pharmacoeconomic analysis, communication and patient advocacy.
	Since 2010, MA Provider is one of the main consulting company in healthcare, located in italy, with focus on market access and public affairs. With iso 9001:2015 certification, We combine our expertise in pricing, HE, national and regional market access, public affairs and communication with excellence in quality and speed, putting our customer Needs at the center of our activity. We are focused mainly on specialty care drugs (oncology, rare diseases, infections, biotechnology), medical devices and recently on ATMPs.
	QuintilesIMS helps customers drive healthcare forward by combining data, technology and services in new ways. From clinical to commercial to real-world insights, we help improve clinical trials, patient outcomes, economic modeling and market access.
	SBU evaluates methods used by medical and social services. SBU is an independent national authority, tasked by the government with assessing health care and social service interventions from a broad perspective, covering medical, economic, ethical and social aspects. SBU assessments are based on ‘systematic literature reviews’ of published research. The review method developed by SBU is thorough and rigorous. SBU was founded in 1987. We are one of the oldest HTA (Health Technology Assessment) organisations in the world.